26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)

Read full text Summarise with VIRAT
Authors: Patrick Yue, Lingling Gu, Weihong Li, Haiyan Li, Yue Dun, jie pan, Yida Tang, Qunsheng Ji
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health RNA Interference and Gene Delivery Lipid metabolism and disorders

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A267–A267
Publication date
27 March 2026
Language
EN